# Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma

> **NCT00316511** · PHASE1 · COMPLETED · sponsor: **Agenus Inc.** · enrollment: 21 (actual)

## Conditions studied

- Malignancies
- B-Cell Lymphoma

## Interventions

- **DRUG:** Aroplatin

## Key facts

- **NCT ID:** NCT00316511
- **Lead sponsor:** Agenus Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-06
- **Final completion:** —
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2008-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00316511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00316511, "Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00316511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*